
Season 2 Wrap-Up: Thank You, Reflections, and What Comes Next JACC This Week
Apr 7, 2026 - 04:13
Radio and PodcastLive Radio & Podcasts
In this episode of JACC This Week, Dr. Carolyn Lam and Dr. Harlan Krumholz spotlight a mini-focus issue on hypertrophic cardiomyopathy (HCM), a field undergoing rapid transformation. The discussion centers on the MAPLE-H...
March 3, 2026: Hypertrophic Cardiomyopathy in Focus—MAPLE-HCM Trial, Myosin Inhibitors & What Improvement Really Means JACC This Week is an episode from JACC's Audio Podcasts by American College of Cardiology. In this episode of JACC This W...
This episode belongs to JACC's Audio Podcasts.
Use the player on this page to stream the episode online.
Published Mar 3, 2026, 18:10 long, audio available.
In this episode of JACC This Week, Dr. Carolyn Lam and Dr. Harlan Krumholz spotlight a mini-focus issue on hypertrophic cardiomyopathy (HCM), a field undergoing rapid transformation. The discussion centers on the MAPLE-HCM trial comparing aficamten and metoprolol in symptomatic obstructive HCM, highlighting multidomain response analysis and what it means to measure meaningful improvement. Beyond gradients and biomarkers, the conversation explores a critical question: when physiologic surrogates improve, how should we interpret patient-centered outcomes? Framed by the Editor's Page, "What Does Improvement Mean?", this episode examines the evolving role of myosin inhibitors, disease modification, and the tension between surrogate markers and real-world clinical benefit. Additional highlights include disaggregation of Asian ethnicities in heart failure quality-of-care research and emerging evidence on AI-driven ECG models to predict incident heart failure—underscoring JACC's commitment to precision, equity, and innovation. This issue reflects a broader shift across cardiology: transforming once-static diseases into treatable chronic conditions guided by rigorous evidence.
You can listen to March 3, 2026: Hypertrophic Cardiomyopathy in Focus—MAPLE-HCM Trial, Myosin Inhibitors & What Improvement Really Means JACC This Week online on Radio and Podcast. Open the player on this page to stream the available audio.
March 3, 2026: Hypertrophic Cardiomyopathy in Focus—MAPLE-HCM Trial, Myosin Inhibitors & What Improvement Really Means JACC This Week is an episode from JACC's Audio Podcasts by American College of Cardiology.
This episode is 18:10 long.
This episode was published on Mar 3, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from JACC's Audio Podcasts when more episodes are available from the podcast feed.
You can listen to March 3, 2026: Hypertrophic Cardiomyopathy in Focus—MAPLE-HCM Trial, Myosin Inhibitors & What Improvement Really Means JACC This Week on this page when the episode audio is available from the podcast feed.
March 3, 2026: Hypertrophic Cardiomyopathy in Focus—MAPLE-HCM Trial, Myosin Inhibitors & What Improvement Really Means JACC This Week is from JACC's Audio Podcasts by American College of Cardiology.
Published Mar 3, 2026 and 18:10 long